For instance, individuals classified as A+T−—indicating abnormal Aβ but normal tau—are often considered to be in a preclinical or early prodromal stage of Alzheimer’s disease. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.